Publications resulting from human brain tissue obtained from the ABBN.
Ali SF, Onaivi ES, Dodd PR, Cadet JL, Schenk S, Kuhar MJ, and Koob GF. (2011) Understanding the global problem of drug addiction is a challenge for IDARS Scientists. Current neuropharmacology. 9: 2-7.
Bastian I, Tam Tam S, Zhou XF, Kazenwadel J, Van der Hoek M, Michael MZ, Gibbins I, and Haberberger RV. (2011) Differential expression of microRNA-1 in dorsal root ganglion neurons. Histochem Cell Biol. 135: 37-45.
Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, Mills RA, Danoy P, Casson R, Viswanathan AC, Liu JZ, Landers J, Henders AK, Wood J, Souzeau E, Crawford A, Leo P, Wang JJ, Rochtchina E, Nyholt DR, Martin NG, Montgomery GW, Mitchell P, Brown MA, Mackey DA, and Craig JE. (2011) Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet. 43: 574-578.
Chan SW, Dunlop RA, Rowe A, Double KL, and Rodgers KJ. (2011) L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro. Exp Neurol.
Cheng D, Jenner AM, Shui G, Cheong WF, Mitchell TW, Nealon JR, Kim WS, McCann H, Wenk MR, Halliday GM, and Garner B. (2011) Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS One. 6: e17299.
Chen-Plotkin AS, Martinez-Lage M, Sleiman PM, Hu W, Greene R, Wood EM, Bing S, Grossman M, Schellenberg GD, Hatanpaa KJ, Weiner MF, White CL, 3rd, Brooks WS, Halliday GM, Kril JJ, Gearing M, Beach TG, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Pickering-Brown SM, Snowden J, van Swieten JC, Heutink P, Seelaar H, Murrell JR, Ghetti B, Spina S, Grafman J, Kaye JA, Woltjer RL, Mesulam M, Bigio E, Llado A, Miller BL, Alzualde A, Moreno F, Rohrer JD, Mackenzie IR, Feldman HH, Hamilton RL, Cruts M, Engelborghs S, De Deyn PP, Van Broeckhoven C, Bird TD, Cairns NJ, Goate A, Frosch MP, Riederer PF, Bogdanovic N, Lee VM, Trojanowski JQ, and Van Deerlin VM. (2011) Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol. 68: 488-497.
Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C, and Cappai R. (2011) The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain research. 1378: 137-143.
Dalton VS, Long LE, Weickert CS, and Zavitsanou K. (2011) Paranoid schizophrenia is characterized by increased CB1 receptor binding in the dorsolateral prefrontal cortex. Neuropsychopharmacology. 36: 1620-1630.
Deep-Soboslay A, Benes FM, Haroutunian V, Ellis JK, Kleinman JE, and Hyde TM. (2011) Psychiatric brain banking: three perspectives on current trends and future directions. Biol Psychiatry. 69: 104-112.
Donkin JJ, Cernak I, Blumbergs PC, and Vink R. (2011) A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. J Neurotrauma. 28: 217-224.
Elliott DA, Tsoi K, Holinkova S, Chan SL, Kim WS, Halliday GM, Rye KA, and Garner B. (2011) Isoform-specific proteolysis of apolipoprotein-E in the brain. Neurobiol Aging. 32: 257-271.
Etheridge N, Mayfield RD, Harris RA, and Dodd PR. (2011) Identifying changes in the synaptic proteome of cirrhotic alcoholic superior frontal gyrus. Current neuropharmacology. 9: 122-128.
Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, Cao D, Rigopoulos A, Cartwright GA, O'Keefe G, Gong S, Adlard PA, Barnham KJ, Rowe CC, Masters CL, Kudo Y, Cappai R, Yanai K, and Villemagne VL. (2011) 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain. 134: 1089-1100.
Frank E, Newell KA, and Huang XF. (2011) Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age. Schizophr Res. 128: 56-60.
Frugier T, Crombie D, Conquest A, Tjhong F, Taylor C, Kulkarni T, McLean C, and Pebay A. (2011) Modulation of LPA receptor expression in the human brain following neurotrauma. Cell Mol Neurobiol. 31: 569-577.
Gibbons AS, Udawela M, Jeon WJ, Seo MS, Brooks L, and Dean B. (2011) The neurobiology of APOE in schizophrenia and mood disorders. Frontiers in bioscience : a journal and virtual library. 16: 962-979.
Halliday GM, and Stevens CH. (2011) Glia: initiators and progressors of pathology in Parkinson's disease. Mov Disord. 26: 6-17.
Halliday GM, Song YJ, and Harding AJ. (2011) Striatal β−amyloid in dementia with Lewy bodies but not Parkinson's disease. J Neural Transm. 118: 713-719.
Halliday GM, Holton JL, Revesz T, and Dickson DW. (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta neuropathologica. 122: 187-204.
Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P, Cantwell LB, Han MR, Dillman A, van der Brug MP, Gibbs JR, Cookson MR, Hernandez DG, Singleton AB, Farrer MJ, Yu CE, Golbe LI, Revesz T, Hardy J, Lees AJ, Devlin B, Hakonarson H, Muller U, and Schellenberg GD. (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 43: 699-705.
Kril JJ, and Halliday GM. (2011) Pathological staging of frontotemporal lobar degeneration. J Mol Neurosci. 45: 379-383.
Kuo SW, and Dodd PR. (2011) Electrically evoked synaptosomal amino acid transmitter release in human brain in alcohol misuse. Neurosignals. 19: 117-127.
Lewohl JM, Nunez YO, Dodd PR, Tiwari GR, Harris RA, and Mayfield RD. (2011) Up-regulation of MicroRNAs in brain of human alcoholics. Alcohol Clin Exp Res. 35: 1928-1937.
Love S, and McLean C. (2011) Overview and recent advances in neuropathology. Pathology. 43: 87.
MacKay RK, Colson NJ, Dodd PR, and Lewohl JM. (2011) Differential expression of 14-3-3 isoforms in human alcoholic brain. Alcohol Clin Exp Res. 35: 1041-1049.
Mair N, Benetti C, Andratsch M, Leitner MG, Constantin CE, Camprubi-Robles M, Quarta S, Biasio W, Kuner R, Gibbins IL, Kress M, and Haberberger RV. (2011) Genetic evidence for involvement of neuronally expressed S1P1 receptor in nociceptor sensitization and inflammatory pain. PLoS One. 6: e17268.
Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, Hill AF, and McLean C. (2011) Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology. 43: 93-102.
Nath S, Goodwin J, Engelborghs Y, and Pountney DL. (2011) Raised calcium promotes α-synuclein aggregate formation. Mol Cell Neurosci. 46: 516-526.
Pamphlett R, and Kum Jew S. (2011) Inorganic mercury within motor neurons does not cause the TDP-43 changes seen in sporadic ALS. Toxicol Lett. 201: 58-61.
Pamphlett R, Morahan JM, Luquin N, and Yu B. (2011) Looking for differences in copy number between blood and brain in sporadic amyotrophic lateral sclerosis. Muscle Nerve. 44: 492-498.
Piguet O, Petersen A, Yin Ka Lam B, Gabery S, Murphy K, Hodges JR, and Halliday GM. (2011) Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol. 69: 312-319.
Piguet O, Halliday GM, Reid WG, Casey B, Carman R, Huang Y, Xuereb JH, Hodges JR, and Kril JJ. (2011) Clinical phenotypes in autopsy-confirmed Pick disease. Neurology. 76: 253-259.
Pountney DL, Dickson TC, Power JH, Vickers JC, West AJ, and Gai WP. (2011) Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurotox Res. 19: 115-122.
Proctor DT, Coulson EJ, and Dodd PR. (2011) Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease. Prog Neurobiol. 93: 509-521.
Reid WG, Hely MA, Morris JG, Loy C, and Halliday GM. (2011) Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). J Neurol Neurosurg Psychiatry. 82: 1033-1037.
Santarelli DM, Beveridge NJ, Tooney PA, and Cairns MJ. (2011) Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry. 69: 180-187.
Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, and Evin G. (2011) Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Neurobiol Dis. 43: 176-183.
Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, and Halliday GM. (2011) Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord. 26: 256-263.
Scott HA, Gebhardt FM, Mitrovic AD, Vandenberg RJ, and Dodd PR. (2011) Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease. Neurobiol Aging. 32: 553 e551-511.
Sheedy D, Harding A, Say M, Stevens J, and Kril JJ. (2011) Histological assessment of cerebellar granule cell layer in postmortem brain; a useful marker of tissue integrity? Cell and tissue banking.
Shine JM, Halliday GM, Naismith SL, and Lewis SJ. (2011) Visual misperceptions and hallucinations in Parkinson's disease: dysfunction of attentional control networks? Mov Disord. 26: 2154-2159.
Simon S, Torpy D, Brophy B, Blumbergs P, Selva D, and Crompton JL. (2011) Neuro-ophthalmic manifestations and outcomes of pituitary apoplexy - a life and sight-threatening emergency. The New Zealand medical journal. 124: 52-59.
Slee M, Finkemeyer J, Krupa M, Raghupathi R, Gardner J, Blumbergs P, Agzarian M, and Thyagarajan D. (2011) A novel mitochondrial DNA deletion producing progressive external ophthalmoplegia associated with multiple sclerosis. J Clin Neurosci. 18: 1318-1324.
Song YJ, Huang Y, and Halliday GM. (2011) Clinical correlates of similar pathologies in parkinsonian syndromes. Mov Disord. 26: 499-506.
Strang F, Scheichl A, Chen YC, Wang X, Htun NM, Bassler N, Eisenhardt SU, Habersberger J, and Peter K. (2011) Amyloid plaques dissociate pentameric to monomeric C-Reactive protein: A novel pathomechanism driving cortical inflammation in Alzheimer's disease? Brain Pathol.
Sun MT, Wong CX, Casson R, and Selva D. (2011) Trends and impact of ophthalmology research. Ophthalmology. 118: 1216 e1213-1214.
Tam Tam S, Bastian I, Zhou XF, Vander Hoek M, Michael MZ, Gibbins IL, and Haberberger RV. (2011) MicroRNA-143 expression in dorsal root ganglion neurons. Cell Tissue Res. 346: 163-173.
Taqi MM, Bazov I, Watanabe H, Sheedy D, Harper C, Alkass K, Druid H, Wentzel P, Nyberg F, Yakovleva T, and Bakalkin G. (2011) Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics. Addict Biol. 16: 499-509.
Taqi MM, Bazov I, Watanabe H, Nyberg F, Yakovleva T, and Bakalkin G. (2011) Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain. Brain research. 1385: 18-25.
Udawela M, Scarr E, Hannan AJ, Thomas EA, and Dean B. (2011) Phospholipase C beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness. Aust N Z J Psychiatry. 45: 140-147.
Wang YJ, Wang X, Lu JJ, Li QX, Gao CY, Liu XH, Sun Y, Yang M, Lim Y, Evin G, Zhong JH, Masters C, and Zhou XF. (2011) p75NTR regulates Aβ deposition by increasing Aβ production but inhibiting Aβ aggregation with its extracellular domain. J Neurosci. 31: 2292-2304.
Wang D, and Owler BK. (2011) Expression of AQP1 and AQP4 in paediatric brain tumours. J Clin Neurosci. 18: 122-127.
Yang M, Lim Y, Li X, Zhong JH, and Zhou XF. (2011) Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with Huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing. The Journal of biological chemistry. 286: 16272-16284.
Yu H, Yang M, Wang Y, Xiao R, and Zhou XF. (2011) p75NTR is mainly responsible for Aβ toxicity but not for its internalization: a primary study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.
Zemtsova I, Gorg B, Keitel V, Bidmon HJ, Schror K, and Haussinger D. (2011) Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 54: 204-215.
Zeng F, Lu JJ, Zhou XF, and Wang YJ. (2011) Roles of p75NTR in the pathogenesis of Alzheimer's disease: A novel therapeutic target. Biochem Pharmacol. 82: 1500-1509.
Zhou J, Broe M, Huang Y, Anderson JP, Gai WP, Milward EA, Porritt M, Howells D, Hughes AJ, Wang X, and Halliday GM. (2011) Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease. Acta neuropathologica. 121: 695-704.
Zhou XF, and Wang YJ. (2011) The p75NTR extracellular domain: A potential molecule regulating the solubility and removal of amyloid-beta. Prion. 5: 161-163.